Clinical Trial Update: "Galectin-3 as a Marker of Subclinical Inflammation in FMF"

View source ↗

Summary

A completed clinical trial evaluating galectin-3 as a marker of subclinical inflammation in familial Mediterranean fever.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Mediterranean Fever

Snippet

Sponsor: Turkish League Against Rheumatism | Conditions: Ailesel Akdeniz Ateşi | Status: COMPLETED